Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"MAPK inhibition"”.

  1. Targeting pro-inflammatory mediators to treat visceral pain

    … is mediated by TRPV1 signalling and p38 MAPK activity respectively, downstream of TNFR1 receptor activation. I therefore sought to investigate whether TNFR1-evoked p38 MAPK activity is also involved in TNFα sensitisation of colonic afferent responses to capsaicin and noxious distension of …

    cambridge Repository record for Targeting pro-inflammatory mediators to treat visceral pain (opens in a new tab)

  2. The Role of the Mitogen Activated Protein Kinase Pathway in Cisplatin and Noise-Induced Hearing Loss

    … loss and the mitogen activated protein kinase (MAPK) pathway is one. The MAPK pathway consists of a phosphorylation cascade with RAF, MEK1/2, ERK1/2 as the main three kinases that effect a multitude of cellular processes. The MAPK pathway has been associated with hearing loss; however, its exact …

    creighton Repository record for The Role of the Mitogen Activated Protein Kinase Pathway in Cisplatin and Noise-Induced Hearing Loss (opens in a new tab)

  3. Investigation of the roles of ion channels in the development of the sea urchin embryo

    … Nodal expression occurs downstream of p38 MAPK, which is transiently, asymmetrically inactive on the presumptive dorsal side of the blastula embryo. VHA activity is required for that transient inactivation of p38 MAPK, and it is required for the subsequent spatial restriction of Nodal …

    bu Repository record for Investigation of the roles of ion channels in the development of the sea urchin embryo (opens in a new tab)

  4. Leveraging copper chelators as targeted therapy for BRAFV600E mutant thyroid cancer

    … side effects, and thus may find use in long-term inhibition of BRAFV600E signaling in PTC. </p><p>Here I test the ability of Cu chelator TM to inhibit tumor growth in BRAFV600E-mutant PTC. TM inhibited MEK1/2 kinase activity and transformed growth of human BRAFV600E-mutant PTC cells as well as or …

    duke Repository record for Leveraging copper chelators as targeted therapy for BRAFV600E mutant thyroid cancer (opens in a new tab)

  5. Combinatorial Modulation of Multiple Signaling Pathways to Gain Therapeutic Response in Breast and Prostate Cell Carcinomas

    … activation of PARP1 which could be suppressed by inhibition of ERBB1, MEKl , PI3 kinase or PARP1. Therefore, the combination of hCG, lovastatin and radiation may represent a novel approach to kill prostate cancer cells and potential new therapy.

    vcu Repository record for Combinatorial Modulation of Multiple Signaling Pathways to Gain Therapeutic Response in Breast and Prostate Cell Carcinomas (opens in a new tab)